PRIMPOL and cancer: Further studies have shown that loss of PRIMPOL leads to increased cellular sensitivity to DNA cross-linking agents such as mitomycin C, suggesting that repriming of PRIMPOL may represent a novel target for improving the sensitivity of cancer cells to DNA-damaging chemotherapies [68, 69].